IDEAS home Printed from https://ideas.repec.org/a/ann/journl/v19y2016i3p155-168.html
   My bibliography  Save this article

Kontrowersje zwiazane z reklamowaniem lekow. Analiza porównawcza Polski i Stanów Zjednoczonych /Controversial Advertising of Medicines. A Comparison between Poland and the United States

Author

Listed:
  • Marta Makowska

    (Warsaw University of Life Sciences , Poland)

Abstract

For many years, the subject of aggressive marketing campaigns conducted by pharmaceutical companies has been raised in Poland. Drug ads are everywhere, on television, the radio, magazines and on the Internet. Therefore, it is extremely important is to ensure both their legal and ethical dimension. In my article I will present the differences between direct-to-consumer advertising of medicines in Poland and in the US. The dissimilarities result mainly from differences in legislation. In Poland the law is much stricter than in the US. For example, in the United States companies are allowed to advertise prescription drugs directly to patients. In the whole of the European Union, and thus in Poland, it is strictly prohibited. The article will present other regulations existing in Poland and in the United States and it will compare them. It will show examples of violations of the law and ethics in the advertising of medicine in both countries. It will briefly outline the negative consequences of unacceptable pharmaceutical marketing.

Suggested Citation

  • Marta Makowska, 2016. "Kontrowersje zwiazane z reklamowaniem lekow. Analiza porównawcza Polski i Stanów Zjednoczonych /Controversial Advertising of Medicines. A Comparison between Poland and the United States," Annales. Ethics in Economic Life, University of Lodz, Faculty of Economics and Sociology, vol. 19(3), pages 155-168, September.
  • Handle: RePEc:ann:journl:v:19:y:2016:i:3:p:155-168
    as

    Download full text from publisher

    File URL: http://www.annalesonline.uni.lodz.pl/archiwum/2016/2016_3_makowska_155_168.pdf
    Download Restriction: no
    ---><---

    More about this item

    Keywords

    pharmaceutical industry; advertisement; drugs; law; ethics;
    All these keywords.

    JEL classification:

    • I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
    • M31 - Business Administration and Business Economics; Marketing; Accounting; Personnel Economics - - Marketing and Advertising - - - Marketing
    • M38 - Business Administration and Business Economics; Marketing; Accounting; Personnel Economics - - Marketing and Advertising - - - Government Policy and Regulation

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ann:journl:v:19:y:2016:i:3:p:155-168. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Joanna Dzionek-Kozlowska (email available below). General contact details of provider: https://edirc.repec.org/data/welodpl.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.